Nightingale Health Oyj B (HEALTH.HE) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Technology · Finland · ISIN FI4000490875

Price
1.40 EUR
Market cap
84.20 m EUR
P/E (2026)
–
P/S (2026)
15.30
Dividend yield
0.00 %
Net margin
-335.73 %
Return on equity (ROE)
-37.90 %
Return on assets (ROA)
-31.82 %

Nightingale Health Oyj B financials

Fiscal year20252026
Revenue4.69 m EUR5.50 m EUR
Gross profit3.56 m EUR2.84 m EUR
Operating income-19.42 m EUR-18.81 m EUR
EBIT-17.12 m EUR-18.10 m EUR
Net income-18.46 m EUR-18.47 m EUR
Diluted EPS – continuing operations-0.31 EUR-0.31 EUR

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Nightingale Health Oyj B

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. The company has a collaboration with Personalised Health Clinics to incorporate the company's metabolomic blood testing into Personalised Health Clinics' personalized, clinician-led healthcare services. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.